In this dataset, cell retention covers the mechanical and fluidic mechanisms that keep viable cells inside a culture device rather than losing them to the effluent stream — retention efficiency, filter fouling, cell bleed, shear exposure, viable density and membrane pore behaviour are the specific terms used to scope the search. Most of these claims sit in bioreactor and lab-apparatus classes (C12M, B01L) rather than pure cell-biology classes, meaning the inventive step is frequently in the hardware geometry rather than the cell line itself. A filing in this space typically pairs a device claim with a method-of-use claim describing how it maintains viable density over time.

The ranking returned by this dataset covers 10 companies, led by an assignee holding 6 of the 23 records in scope, with the count dropping to 2 by fifth place and 1 by tenth place. That pattern is a short head with a long, thin tail rather than a crowded competitive core, and the leading positions are held by academic and institutional assignees rather than a single large commercial filer. Because the ranked list is the entire dataset returned, not a top-50 or top-100 cut, absence from it does not necessarily mean a company is inactive — it may simply fall outside this specific IPC and keyword scope.

Filing peaked at 6 records in 2022, the highest single year in the dataset, and then declined from 4 records in 2021 to 2 in 2024 — a 50% drop over that span. That said, publication typically lags actual filing by around 18 months, so the apparent low counts in 2025 and 2026 are an artefact of that lag rather than confirmed evidence of a slowdown. The safest reading is that activity crested in 2022 and cooled through the most recently complete year, 2024, without drawing conclusions about the two most recent years.